{"id":882225,"date":"2026-10-30T14:07:10","date_gmt":"2026-10-30T12:07:10","guid":{"rendered":"https:\/\/businesstech.co.za\/news\/?p=882225"},"modified":"2026-10-30T14:07:13","modified_gmt":"2026-10-30T12:07:13","slug":"the-one-medication-making-dis-chems-wallet-fat","status":"publish","type":"post","link":"https:\/\/businesstech.co.za\/news\/business\/882225\/the-one-medication-making-dis-chems-wallet-fat\/","title":{"rendered":"The one medication making Dis-Chem&#8217;s wallet fat"},"content":{"rendered":"\n<p>Dis-Chem said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.<\/p>\n\n\n\n<p>Dispensary revenue rose 10% in the six months through August, about double the rate of market-value growth of 5.1%, Chief Executive Officer Rui Morais told reporters Thursday after the company released earnings.<\/p>\n\n\n\n<p>Headline earnings per share, which exclude certain capital items, declined almost 13% in the period as the company absorbed upfront investment in its innovation unit \u2014 known as X, bigly labs \u2014 which designed its new rewards program. That\u2019s even as revenue rose 8%.<\/p>\n\n\n\n<p>Dis-Chem shares fell as much as 12% in early trade in Johannesburg on Friday.<\/p>\n\n\n\n<p>The continued penetration of GLP-1 medicines was one contributor to the revenue increase, alongside the company\u2019s Better Rewards incentive that gives customers discounts on other purchases in its stores.<\/p>\n\n\n\n<p>With GLP-1 medicines costing about R3,000 per prescription, their rapid uptake is disproportionately lifting the value of Dis-Chem\u2019s pharmacy sales.<\/p>\n\n\n\n<p>\u201cYou\u2019re selling a lot more very expensive products,\u201d Morais said.<\/p>\n\n\n\n<p>The company doesn\u2019t disclose GLP-1 revenue, but Morais said sales have compounded at \u201chundreds of percent\u201d over roughly the past 12 to 18 months and continue to show significant month-on-month growth.<\/p>\n\n\n\n<p>Cheaper generic medicines are poised to enter South Africa, potentially widening access even as lower prices temper their contribution to dispensary revenue growth.<\/p>\n\n\n\n<p>Dis-Chem is meanwhile investing in data-led promotions designed to encourage customers to shop more frequently and buy more. <\/p>\n\n\n\n<p>Its rewards program has 8.2 million active members, who account for 86.1% of sales, and has returned R1.5 billion in value to customers since its October 2025 launch.<\/p>\n\n\n\n<p>Customers can \u201cstack\u201d discounts through actions such as using Dis-Chem\u2019s pharmacy services or paying with a Capitec bank card. <\/p>\n\n\n\n<p>Among existing active customers, shopping frequency increased by two visits, while average basket value rose by 3.5%.<\/p>\n\n\n\n<p>The next step is to use the customer data generated by the program to increasingly personalise discounts. Dis-Chem said future promotional investment will be driven by predictive and adaptive offers developed through its X, Bigly Labs innovation unit.<\/p>\n\n\n\n<p>Morais said investment costs are now largely embedded in the business, setting the company up for stronger earnings growth in the second half.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dis-Chem said demand for GLP-1 medicines is helping drive the company&#8217;s growth, as South Africans increasingly turn to the obesity and diabetes treatment.<\/p>\n","protected":false},"author":59,"featured_media":863538,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_sma_x_autopost_status":"posted","_sma_x_autopost_error":"","_sma_x_post_id":"2116141326035034560","_sma_facebook_post_id":"191437357620492_2254674788686253","_sma_instagram_post_id":"18028689758920042","_sma_x_attempts":1,"footnotes":""},"categories":[9872],"tags":[11643,26676,26997],"class_list":["post-882225","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-dischem","tag-glp-1","tag-rui-morais"],"_links":{"self":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts\/882225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/comments?post=882225"}],"version-history":[{"count":2,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts\/882225\/revisions"}],"predecessor-version":[{"id":882230,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/posts\/882225\/revisions\/882230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/media\/863538"}],"wp:attachment":[{"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/media?parent=882225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/categories?post=882225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/businesstech.co.za\/news\/wp-json\/wp\/v2\/tags?post=882225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}